The Endocannabinoid System and Myelin Regeneration: A Clinical Breakdown
A new preclinical study from Complutense University has found that CB1 receptor myelin repair mechanisms depend on intact endocannabinoid signaling at a critical cellular window. Researchers removed CB1 receptors specifically from newly formed…
Long-Term Cannabis Therapy May Change MS Spasticity Outcomes
Cannabis for MS spasticity was associated with meaningful symptom improvement in a new meta-analysis involving 2,544 multiple sclerosis patients across nine trials. The strongest benefits emerged with longer treatment duration, while short-term effects…
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
A new consensus from Italian neurologists proposes enhancing the endocannabinoid system multiple sclerosis treatment approach for patients with relapse-free disease. The algorithm combines cannabinoid agents with lifestyle interventions to address…
Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People With Multiple Sclerosis.
A real-time smartphone-based study of 258 MS patients revealed that higher pain levels drive increased cannabis use and decreased alcohol consumption. This research using ecological momentary assessment provides clinical evidence that MS patients make…
A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling.
Researchers found that cannabis essential oil neuroinflammation reduction occurred through CB2 receptor activation in an experimental multiple sclerosis model. The sesquiterpene-rich formulation improved pain, motor function, and emotional symptoms…
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
Research examining cannabis cognitive effects in multiple sclerosis patients found that cannabis users report greater perceived cognitive deficits than non-users. This cross-sectional study of 847 MS patients provides important insights into the…
Daily Temporal Associations Between Psychoactive Substance Use and MS Symptoms
This study investigates psychoactive substance use multiple sclerosis patients experience daily. Using ecological momentary assessment, it tracks symptom fluctuations and substance use patterns. Findings reveal complex, symptom-dependent relationships…
Ozone Smog and Increased MS Risk in Children: Environmental Insights
This study highlights the link between air pollution autoimmune neurological conditions and increased risk of multiple sclerosis in children. It adds to evidence that environmental factors like ozone exposure may trigger autoimmune diseases. Clinicians…
Wim Hof Method and Lifestyle Changes Reduce Inflammation in MS
The Wim Hof method inflammation MS study highlights lifestyle changes that reduce inflammation in multiple sclerosis. This approach combines cold exposure, breathing, and meditation. It offers promising complementary strategies for managing MS symptoms.
Scientists Zero In on CD29 Protein Marker as Key Driver of MS in New Study
The cd29 protein marker multiple sclerosis study highlights its role as a key driver of brain inflammation. This discovery could lead to improved biomarkers and targeted treatments. Researchers emphasize the importance of this protein in understanding MS…
